Bictegravir and emtricitabine and tenofovir only product in oral dose form
|
Product containing precisely bictegravir (as bictegravir sodium) 50 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug)
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
Id1304317003
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSEmtricitabine
Has precise active ingredientEmtricitabine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSTenofovir alafenamide
Has precise active ingredientTenofovir alafenamide fumarate
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSBictegravir
Has precise active ingredientBictegravir sodium
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg